Background and Aim Blood transfusion is a frequent and integral part of critical patient care. Even though life-saving, it could be occasionally risky and result in a spectrum of adverse events. Haemovigilance programme is a standard set-up to monitor the entire transfusion chain, evaluate and analyse the data to improve patient's safety. The haemovigilance programme has been established in India very recently. We report the implemented haemovigilance programme at a tertiary care hospital in the north-east of India.Results A total of 51 000 blood components were transfused and 106 adverse events reported during the period of the study. The major stakes of adverse events were febrile non-haemolytic transfusion reactions (50%), pruritus (17Á92%) and rigour/chills (11Á32%). All the adverse events were found to be Grade 1 (non-severe) type, and there were no severe or life-threatening adverse events.